Diabetes
From the Journals
What is the dark side of GLP-1 receptor agonists?
“When millions of people are treated with medications like semaglutide, even relatively rare side effects occur in a large number of individuals...
From the Journals
Insufficient sleep impairs women’s insulin sensitivity
“What we’re seeing is that more insulin is needed to normalize glucose levels in the women under conditions of sleep restriction.”
Latest News
Bariatric surgery still best option for some with obesity
“Sometimes we might need to go straight to surgery instead of going through medications first, because it may be the most effective and evidence-...
From the Journals
Study confirms link between red meat and diabetes risk
Those who consumed more red meat had a higher BMI, higher total energy intake, and greater likelihood of being a smoker.
Latest News
PREVENT: AHA’s new risk calculator incorporates CKM health
PREVENT is for use in adults aged 30-79 years and estimates the 10- and 30-year risk of total CVD including, for the first time, heart failure.
Latest News
‘Love more’: Why doctors should promote social connection
Embracing community and close relationships helps people live longer and be happier.
Latest News
T2D: Real benefits of new oral antidiabetic drugs
What about in the real world? Could combining SGLT2 inhibitors with GLP-1R agonists be even more effective?
Latest News
Does laughter offer better blood glucose control?
Several diabetes educators have reported that humor can encourage and support diabetes management, said Dr. David Greene.
Conference Coverage
Low-salt diet cut BP by 6 mm Hg in 1 week: CARDIA-SSBP
“The blood pressure reduction we see here is ... comparable to that produced by one antihypertensive medication,” said Dr. Deepak Gupta.
From the Journals
People with diabetes have a higher risk of colon cancer: Study
The authors concluded that increased referrals for colonoscopies among people with diabetes, particularly among those newly diagnosed, could...
Latest News
GLP-1s don’t appear to worsen diabetic retinopathy
The findings do not obviate the need for providers to have a conversation about the potential risks to vision posed by the drug.